Clinical Research Directory
Browse clinical research sites, groups, and studies.
Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy
Sponsor: Kyungpook National University Hospital
Summary
Cytoreductive surgery with intraperitoneal chemotherapy is one of the most important treatments for patients with colorectal cancer and peritoneal metastasis. For the best survival rates, complete removal of all metastatic lesions is the most important part of treatment, and various surgical procedures are required for the complete cytoreduction. Therefore, the postoperative morbidity rates are higher than those of localized colon cancer surgeries and patients can experience a prolonged recovery period and deterioration of physical activities over a long period. The aim of this study is to investigate the change of quality of life after cytoreductive surgery and intraperitoneal chemotherapy for colorectal cancer.
Official title: Recovery of Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer and Pseudomyxoma Peritonei
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
0
Start Date
2018-10-01
Completion Date
2025-12-31
Last Updated
2026-08-05
Healthy Volunteers
No
Conditions
Interventions
Cytoreductive surgery and intraperitoneal chemotherapy
Cytoreductive surgery and intraperitoneal chemotherapy for colorectal cancer or pseudomyxoma peritonei. Either early postoperative intraperitoneal chemotherapy (EPIC) or hyperthermic intraperitoneal chemotherapy (HIPEC) is used for intraperitoneal chemotherapy.
Locations (1)
Kyungpook National University Chilgok Hospital
Daegu, South Korea